Mab Forward Looking Statements News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Mab Forward Looking Statements. Real-time updates on events, politics, business and more.

I-Mab Announces First Patient Dosed in Phase 3 Registrational Study of CD47 Antibody Lemzoparlimab in MDS in China

April 24, 2023

GAITHERSBURG, Md. and SHANGHAI, April 24, 2023 /PRNewswire/ -- I-Mab (the Company) (Nasdaq: IMAB), a clinical-stage biopharmaceutical company co...

Source: businessinsider.com